膀胱癌局部分期的术前影像学检查
膀胱癌预后主要取决于局部病变范围,尤其是否侵犯肌层,因此分为非肌层浸润性和肌层浸润性膀胱癌,后者常需考虑膀胱切除术。术前精确分期至关重要,但最佳影像 modality 仍有争议。经尿道膀胱肿瘤电切术(TURBT)后行CT尿路造影是目前推荐的分期方法,但存在高分期不足率。本文综述近期文献,比较不同影像学方法评估肌层侵犯和淋巴结受累的优势。
要点
- 膀胱癌局部分期核心是判断有无肌层侵犯,肌层浸润性常提示需考虑膀胱切除术。
- TURBT后CT尿路造影为目前推荐分期方案,但分期不足率高。
- 不同影像学方法评估肌层侵犯和淋巴结受累各有优势,最佳术前影像尚存争议。
核心结论
- 膀胱癌术前精确分期对治疗决策至关重要,但最佳术前影像学方法仍有争议;TURBT后CT尿路造影是目前推荐方法,但分期不足率高;不同影像学方法评估肌层侵犯和淋巴结受累各有优势。
研究设计与样本
- 综述,检索并比较近期文献中用于膀胱癌膀胱切除术前评估肌层侵犯和淋巴结受累的不同影像学方法。
临床应用与阅片要点
- 目前推荐经尿道膀胱肿瘤电切术(TURBT)后行CT尿路造影进行膀胱癌分期。
- TURBT后CT尿路造影存在较高的分期不足率。
- 评估肌层侵犯和淋巴结受累时需了解不同影像学方法各自的优势。
局限性
- 最佳术前影像学方法仍有争议。
- TURBT后CT尿路造影存在较高的分期不足率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Bladder cancer is the ninth most common cancer, expected to lead to an estimated 17,670 deaths in the United States in 2019. Clinical management and prognosis of bladder cancer mainly depend on the extent of locoregional disease, particularly whether bladder muscle is involved. Therefore, bladder cancer is often divided into superficial, non-muscle-invasive bladder cancer and muscle-invasive bladder cancer; the latter often prompts consideration for cystectomy. While precise staging prior to cystectomy is crucial, the optimal preoperative imaging modality used to stage the disease remains controversial. Transurethral resection of bladder tumor (TURBT) followed by computed tomography (CT) urography is the current recommended approach for staging bladder cancer but suffers from a high rate of understaging. We review the recent literature and compare different imaging modalities for assessing the presence of muscle invasion and lymph node involvement prior to cystectomy and highlight the advantages of each modality.
引用
- Mirmomen SM, Shinagare AB, Williams KE, et al. Preoperative imaging for locoregional staging of bladder cancer. Abdom Radiol (NY). 2019. PMID: 31377833. doi:10.1007/s00261-019-02168-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。